Metformin (Glucophage) - Uses, Side Effects
Glucophage Interactions
Pharmacokinetic Interactions
1. Renal Transport Inhibition
Drugs competing with metformin's tubular secretion increase plasma concentrations by 40-60%:
Interacting Drug | Mechanism | Clinical Effect | Management |
---|---|---|---|
Cimetidine | OCT2 inhibition | ↑ Metformin AUC by 60% | Avoid combination or reduce metformin dose |
Dolutegravir | MATE1 inhibition | ↑ Metformin Cmax by 79% | Limit metformin to 1000mg/day |
2. Nephrotoxic Agents
- NSAIDs: Reduce renal perfusion → 30% higher metformin levels
- Vancomycin: Additive tubular toxicity
- Aminoglycosides: Synergistic nephrotoxicity
High-Risk Category X Interactions
Iodinated Contrast Media
Intravenous contrast increases lactic acidosis risk through:
- Acute kidney injury (incidence 5-15%)
- Impaired metformin excretion
- Dehydration effects
Protocol: Withhold metformin 48 hours pre-procedure in patients with eGFR 30-60
Ethanol Interactions
Alcohol Consumption | Effect | Recommendation |
---|---|---|
Acute binge (>4 drinks) | ↑ Lactate production 300% | Absolute avoidance |
Chronic use | ↓ Hepatic lactate clearance | Limit to 1 drink/day |
Interaction Monitoring Guidelines
Pre-Interaction Screening
- Renal function (eGFR, creatinine)
- Hepatic enzymes
- Acid-base status if symptomatic
Post-Interaction Monitoring
Timeframe | Assessments |
---|---|
48 hours | Renal function, lactate levels |
1 week | Glycemic control, adverse effects |